Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleResults of a phase I trial with Haploidentical mbIL‐21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML.AuthorsCiurea, Stefan O.; Kongtim, Piyanuch; Srour, Samer; Chen, Julianne; Soebbing, Doris; Shpall, Elizabeth; Rezvani, Katayoun; Nakkula, Robin; Thakkar, Aarohi; Troy, Ella C.; Cash, Alex A.; Behbehani, Gregory; Cao, Kai; Schafer, Jolie; Champlin, Richard E.; Lee, Dean A.PublicationAmerican Journal of Hematology, 2024, Vol 99, Issue 5, p890ISSN0361-8609Publication typeArticleDOI10.1002/ajh.27281